Literature DB >> 6294342

A locus that enhances the induction of endogenous ecotropic murine leukemia viruses is distinct from genome-length ecotropic proviruses.

J M Horowitz, R Risser.   

Abstract

The segregation of genes that enhance the induction of ecotropic murine leukemia viruses (In loci) has been compared with the segregation of ecotropic-specific nucleotide sequences in 12 low-leukemic mouse strains and 18 recombinant inbred strains. Endogenous ecotropic viruses of these strains are of genome length and structurally similar to AKR ecotropic proviruses. Low-leukemic strains of related pedigree contain ecotropic proviruses at common integration sites. Loci previously identified which enhance induction of ecotropic viruses (In genes) were correlated with the inheritance of ecotropic viral sequences in inbred low-leukemic mouse strains and in CXB recombinant inbred mouse strains. However, four BXH recombinant inbred strains were observed to possess an In gene(s) yet lack the probed envelope gene region for the corresponding endogenous ecotropic virus. These observations indicate that at least one gene that enhances ecotropic virus expression in vitro is encoded by DNA sequences outside ecotropic proviruses or by subgenomic viral sequences.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294342      PMCID: PMC256354     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Genetic factors in the natural history of murine leukemia virus infection: G. H. A. Clowes Memorial Lecture.

Authors:  W P Rowe
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

2.  A genetic locus for inducibility of C-type in BALB-c cells: the effect of a nonlinked regulatory gene on detection of virus after chemical activation.

Authors:  J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

3.  Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  N Teich; D R Lowy; J W Hartley; W P Rowe
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

4.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

6.  Evidence that the AKR murine-leukemia-virus genome is complete in DNA of the high-virus AKR mouse and incomplete in the DNA of the "virus-negative" NIH mouse.

Authors:  S K Chattopadhyay; D R Lowy; N M Teich; A S Levine; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

7.  Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice.

Authors:  R L Peters; J W Hartley; G J Spahn; L S Rabstein; C E Whitmire; H C Turner; R J Huebner
Journal:  Int J Cancer       Date:  1972-09-15       Impact factor: 7.396

8.  Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  D R Lowy; W P Rowe; N Teich; J W Hartley
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

9.  Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells.

Authors:  S A Aaronson; G J Todaro; E M Scolnick
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

10.  Genetic factors influencing C-type RNA virus induction.

Authors:  J R Stephenson; S A Aaronson
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Mouse chromosome 8.

Authors:  J D Ceci; A J Lusis
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  A single point mutation in the envelope gene is responsible for replication and XC fusion deficiency of the endogenous ecotropic C3H/He murine leukemia virus and for its repair in culture.

Authors:  G Sithanandam; U R Rapp
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Transcription from a spleen necrosis virus 5' long terminal repeat is suppressed in mouse cells.

Authors:  J E Embretson; H M Temin
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line.

Authors:  J E Embretson; H M Temin
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Germ line integration of a murine leukemia provirus into a retroviruslike sequence.

Authors:  J M Horowitz; G D Holland; S R King; R Risser
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

8.  Cytolytic T lymphocyte-defined retroviral antigens on normal cells: encoding by the Akv-1 proviral locus.

Authors:  W R Green; R F Graziano
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Normal expression of polymorphic endogenous retroviral RNA containing segments identical to mink cell focus-forming virus.

Authors:  D E Levy; R A Lerner; M C Wilson
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.